MarketPeel
Chief Executive Officer
Mon, Jul 13, 2026
Jul 13
sold $291.44k of MLYS
10,700 shares @ $27.24
Decreased holdings by -1.70%
14th largest trade (out of 42)
Planned (10b5-1)Positive 90D History
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
70% win rate · +34.2% median edge vs SPY (10 trades, 90-day · small sample)
Price 15% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
MLYSMineralys Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-1.54%
1M-3.97%
3M-14.47%
6M
1Y

Recent insider activity at MLYS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback